{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T02:37:53Z","timestamp":1789007873040,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T00:00:00Z","timestamp":1705536000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001797","name":"Pharmaceutical Research and Manufacturers of America Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001797","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.ejps.2024.106708","type":"journal-article","created":{"date-parts":[[2024,1,21]],"date-time":"2024-01-21T10:07:16Z","timestamp":1705831636000},"page":"106708","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Modifying peptide\/lipid-associated nucleic acids (PLANAs) for CRISPR\/Cas9 ribonucleoprotein delivery"],"prefix":"10.1016","volume":"195","author":[{"given":"Abdulelah","family":"Alhazza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parvin","family":"Mahdipoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryley","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Manda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Lohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keykavous","family":"Parang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8313-0657","authenticated-orcid":false,"given":"Hamidreza Montazeri","family":"Aliabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7630","key":"10.1016\/j.ejps.2024.106708_bib0001","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nature.2016.20988","article-title":"CRISPR gene-editing tested in a person for the first time","volume":"539","author":"Cyranoski","year":"2016","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ejps.2024.106708_bib0002","doi-asserted-by":"crossref","DOI":"10.3390\/v15030690","article-title":"Packaging and uncoating of CRISPR\/Cas ribonucleoproteins for efficient gene editing with viral and non-viral extracellular nanoparticles","volume":"15","author":"Mazurov","year":"2023","journal-title":"Viruses"},{"issue":"9","key":"10.1016\/j.ejps.2024.106708_bib0003","doi-asserted-by":"crossref","DOI":"10.1002\/cbic.202200801","article-title":"Intracellular delivery of mRNA for cell-selective CRISPR\/Cas9 genome editing using lipid nanoparticles","volume":"24","author":"Ma","year":"2023","journal-title":"Chembiochem"},{"key":"10.1016\/j.ejps.2024.106708_bib0004","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jbiotec.2015.04.024","article-title":"Rapid and highly efficient mammalian cell engineering via Cas9 protein transfection","volume":"208","author":"Liang","year":"2015","journal-title":"J. Biotechnol."},{"issue":"6","key":"10.1016\/j.ejps.2024.106708_bib0005","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1021\/acs.molpharmaceut.1c00916","article-title":"Lipid-nanoparticle-based delivery of CRISPR\/Cas9 genome-editing components","volume":"19","author":"Kazemian","year":"2022","journal-title":"Mol. Pharm."},{"issue":"8","key":"10.1016\/j.ejps.2024.106708_bib0006","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.apsb.2021.05.020","article-title":"In vivo delivery of CRISPR-Cas9 therapeutics: progress and challenges","volume":"11","author":"Behr","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"3","key":"10.1016\/j.ejps.2024.106708_bib0007","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1021\/acs.molpharmaceut.0c00969","article-title":"Peptide\/lipid-associated nucleic acids (PLANAs) as a multicomponent siRNA delivery system","volume":"18","author":"Hall","year":"2021","journal-title":"Mol. Pharm."},{"issue":"10","key":"10.1016\/j.ejps.2024.106708_bib0008","doi-asserted-by":"crossref","first-page":"6939","DOI":"10.1021\/acsomega.7b00741","article-title":"Difatty acyl-conjugated linear and cyclic peptides for siRNA delivery","volume":"2","author":"Do","year":"2017","journal-title":"ACS. Omega"},{"issue":"11","key":"10.1016\/j.ejps.2024.106708_bib0009","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1021\/bm100522c","article-title":"Effect of PEGylation on the toxicity and permeability enhancement of chitosan","volume":"11","author":"Casettari","year":"2010","journal-title":"Biomacromolecules."},{"key":"10.1016\/j.ejps.2024.106708_bib0010","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.actbio.2016.07.015","article-title":"PEGylated PAMAM dendrimers: enhancing efficacy and mitigating toxicity for effective anticancer drug and gene delivery","volume":"43","author":"Luong","year":"2016","journal-title":"Acta Biomater."},{"issue":"1","key":"10.1016\/j.ejps.2024.106708_bib0011","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1124\/jpet.114.217208","article-title":"Pegylation improves the pharmacokinetics and bioavailability of small-molecule drugs hydrolyzable by esterases: a study of phospho-Ibuprofen","volume":"351","author":"Mattheolabakis","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"24","key":"10.1016\/j.ejps.2024.106708_bib0012","doi-asserted-by":"crossref","first-page":"10748","DOI":"10.1039\/D1NR02065J","article-title":"Effects of polyethylene glycol on the surface of nanoparticles for targeted drug delivery","volume":"13","author":"Shi","year":"2021","journal-title":"Nanoscale"},{"issue":"3","key":"10.1016\/j.ejps.2024.106708_bib0013","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1248\/bpb.b13-00661","article-title":"Discussion about several potential drawbacks of PEGylated therapeutic proteins","volume":"37","author":"Zhang","year":"2014","journal-title":"Biol. Pharm. Bull."},{"issue":"5","key":"10.1016\/j.ejps.2024.106708_bib0014","doi-asserted-by":"crossref","first-page":"866","DOI":"10.3109\/08923973.2012.666979","article-title":"PEGylation is effective in reducing immunogenicity, immunotoxicity, and hepatotoxicity of alpha-momorcharin in vivo","volume":"34","author":"Zheng","year":"2012","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.ejps.2024.106708_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmpk.2021.100424","article-title":"Difference in the lipid nanoparticle technology employed in three approved siRNA (Patisiran) and mRNA (COVID-19 vaccine) drugs","volume":"41","author":"Suzuki","year":"2021","journal-title":"Drug Metab. Pharmacokinet."},{"issue":"10","key":"10.1016\/j.ejps.2024.106708_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0275263","article-title":"Abundance, efficiency, and stability of reference transcript expression in a seasonal rodent: the Siberian hamster","volume":"17","author":"Stewart","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.ejps.2024.106708_bib0017","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.brainresbull.2019.12.015","article-title":"Validation of reference genes for gene expression analysis following experimental traumatic brain injury in a pediatric mouse model","volume":"156","author":"Zamani","year":"2020","journal-title":"Brain Res. Bull."},{"issue":"6","key":"10.1016\/j.ejps.2024.106708_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0199473","article-title":"CRISPR\/Cas-based customization of pooled CRISPR libraries","volume":"13","author":"Kweon","year":"2018","journal-title":"PLoS. One"},{"issue":"2","key":"10.1016\/j.ejps.2024.106708_bib0019","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ajhg.2017.06.010","article-title":"CRISPR\/Cas9-mediated scanning for regulatory elements required for HPRT1 expression via thousands of large, programmed genomic deletions","volume":"101","author":"Gasperini","year":"2017","journal-title":"Am. J. Hum. Genet."},{"issue":"5","key":"10.1016\/j.ejps.2024.106708_bib0020","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/mabi.201000402","article-title":"Impact of lipid substitution on assembly and delivery of siRNA by cationic polymers","volume":"11","author":"Aliabadi","year":"2011","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.ejps.2024.106708_bib0021","article-title":"Oligodendrogenesis and myelination tracing in a CRISPR\/Cas9-engineered brain microphysiological system","volume":"16","author":"Romero","year":"2022","journal-title":"Front. Cell Neurosci."},{"key":"10.1016\/j.ejps.2024.106708_bib0022","series-title":"Reverse Transfection Using FuGENE\u00ae 6 and FuGENE\u00ae HD","author":"Hook","year":"2023"},{"issue":"2","key":"10.1016\/j.ejps.2024.106708_bib0023","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1021\/bc800428y","article-title":"A biodegradable low molecular weight polyethylenimine derivative as low toxicity and efficient gene vector","volume":"20","author":"Wen","year":"2009","journal-title":"Bioconjug. Chem."},{"issue":"1","key":"10.1016\/j.ejps.2024.106708_bib0024","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1248\/cpb.53.27","article-title":"Effects of poly(ethylene glycol) (PEG) concentration on the permeability of PEG-grafted liposomes","volume":"53","author":"Hashizaki","year":"2005","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"issue":"1","key":"10.1016\/j.ejps.2024.106708_bib0025","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0005-2736(99)00192-3","article-title":"Effect of grafted polyethylene glycol (PEG) on the size, encapsulation efficiency and permeability of vesicles","volume":"1463","author":"Nicholas","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"issue":"7","key":"10.1016\/j.ejps.2024.106708_bib0026","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1208\/s12249-020-01810-0","article-title":"PEGylated lipid polymeric nanoparticle-encapsulated acyclovir for in vitro controlled release and ex vivo gut sac permeation","volume":"21","author":"Mahmood","year":"2020","journal-title":"AAPS. PharmSciTech."},{"key":"10.1016\/j.ejps.2024.106708_bib0027","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejpb.2019.09.004","article-title":"Impact of polyethylene glycol polymers on the physicochemical properties and mucoadhesivity of itraconazole nanoparticles","volume":"144","author":"Machado Cruz","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/j.ejps.2024.106708_bib0028","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11095-007-9348-7","article-title":"Sheddable coatings for long-circulating nanoparticles","volume":"25","author":"Romberg","year":"2008","journal-title":"Pharm. Res."},{"issue":"16","key":"10.1016\/j.ejps.2024.106708_bib0029","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1039\/c2ob27199k","article-title":"A photo-triggerable drug carrier based on cleavage of PEG lipids by photosensitiser-generated reactive singlet oxygen","volume":"11","author":"Komeda","year":"2013","journal-title":"Org. Biomol. Chem."},{"issue":"3","key":"10.1016\/j.ejps.2024.106708_bib0030","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1078\/0171-9335-00363","article-title":"PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles","volume":"83","author":"Mishra","year":"2004","journal-title":"Eur. J. Cell Biol."},{"issue":"7","key":"10.1016\/j.ejps.2024.106708_bib0031","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/ppsc.201300357","article-title":"The cellular interactions of PEGylated gold nanoparticles: effect of PEGylation on cellular uptake and cytotoxicity","volume":"31","author":"Soenen","year":"2014","journal-title":"Particl. Particl. Syst. Character."},{"issue":"sup1","key":"10.1016\/j.ejps.2024.106708_bib0032","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/10717544.2017.1388451","article-title":"Cleavable PEGylation: a strategy for overcoming the \"PEG dilemma\" in efficient drug delivery","volume":"24","author":"Fang","year":"2017","journal-title":"Drug Deliv."},{"issue":"3","key":"10.1016\/j.ejps.2024.106708_bib0033","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1534\/g3.114.015834","article-title":"Comparison of T7E1 and surveyor mismatch cleavage assays to detect mutations triggered by engineered nucleases","volume":"5","author":"Vouillot","year":"2015","journal-title":"G3. (Bethesda)"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098724000198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098724000198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T12:08:27Z","timestamp":1760530107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098724000198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":33,"alternative-id":["S0928098724000198"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2024.106708","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modifying peptide\/lipid-associated nucleic acids (PLANAs) for CRISPR\/Cas9 ribonucleoprotein delivery","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2024.106708","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106708"}}